Fairvalue-Calculator Fairvalue-Calculator
EN DE

BioRem Inc (BRM) Fair Value & Analysis

Industrials · CA · Market cap C$50.0M

BI BioRem Inc BRM · V
PriceC$3.12
Fair ValueC$5.53
Upside+77.2%
Quality95/100
Evidence: High Range C$4.11 – C$6.94

Fair value as of: Jun 24, 2026

From 26 valuation models · updated 5 days ago

Fair value updated Jun 24, 2026 — revised from C$9.09 to C$5.53 (−39.2%) since Jun 23, 2026. Share price −2.2% over the past month.

Price vs Fair Value (12 months)

C$3.60 C$1.92 Fair Value C$5.53 Jun 2025 Jun 2026

12‑month range C$1.92 – C$3.60 · fair‑value band C$4.11 – C$6.94 · the C$3.12 price screens below the C$5.53 fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

BioRem Inc (BRM) currently trades at C$3.12, while our model-based Fair Value estimate is C$5.53 — implying the stock looks roughly 77.2% undervalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, BioRem Inc generated revenue of C$44.4M at a net margin of 11.2%. Revenue grew 44.1% year over year. It earns a return on equity of 38.3%. Net debt stands at C$1.9M. Fundamentals as of Jun 24, 2026

Key figures & financial health

Revenue (TTM) C$44.4M
Revenue growth (YoY) +44.1%
Net margin 11.2%
Return on equity 38.3%
Free cash flow C$7.3M FY2025
P/E ratio 11.4
More key figures
Operating margin 2.7%
EPS (TTM) C$0.2700
EPS growth (YoY) +450%
Net debt C$1.9M FY2023

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

About the company

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States, China, and internationally. In addition, its products are used in wastewater and water treatment plants, municipal solid waste and waste to energy, pet food manufacturing, rendering plants, food and beverage, petrochemical, semiconductor, chemical production facilities industries. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

BioRem Inc reported revenue of C$42.4M in FY2025 versus C$24.5M in FY2021, a compound +14.7%/yr. Reported net income was C$4.8M in FY2025, compounding +38.8%/yr from FY2021.

Revenue +14.7%/yr
FY21 C$24.5M
FY22 C$28.9M
FY23 C$25.2M
FY24 C$37.4M
FY25 C$42.4M
Net income +38.8%/yr
FY21 C$1.3M
FY22 C$1.6M
FY23 C$2.2M
FY24 C$3.0M
FY25 C$4.8M

Open the full interactive analysis →

Similar stocks

6 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
Veralto Corporation VLTO $82.62 $69.11 -16%
Canmax Technologies Co 300390 ¥91.80 ¥10.65 -88%
Zurn Elkay Water Solutions Corporation ZWS $47.37 $23.26 -51%
Kurita Water Industries Ltd KTWIY $122.41 $49.33 -60%
Munters Group MTRS kr 178.10 kr 48.58 -73%
Fujian Longking Co 600388 ¥16.37 ¥16.71 +2%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is BioRem Inc (BRM) undervalued?
As of Jun 24, 2026, our model estimates a fair value of C$5.53 versus a price of C$3.12 — about +77% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BRM?
Our 21-model fair value for BioRem Inc is C$5.53 (as of Jun 24, 2026), built from audited fundamentals. The current price is C$3.12.
What is the quality score of BRM?
BioRem Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BioRem Inc (BRM)?
BioRem Inc reported trailing-twelve-month revenue of about C$44.4M (latest available figure, as of Jun 24, 2026).
What is the net profit margin of BRM?
The net profit margin of BioRem Inc is about 11.2%, meaning it keeps roughly 11.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.